Pulse Biosciences Stock Analysis

Pulse Stock Analysis Notes

About 72.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.82. Pulse Biosciences had not issued any dividends in recent years. Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. Pulse Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 142 people. To find out more about Pulse Biosciences contact Kevin Danahy at 510 906 4600 or learn more at https://www.pulsebiosciences.com.

Pulse Biosciences Investment Alerts

Pulse Biosciences Upcoming and Recent Events

Pulse Largest EPS Surprises

View All Earnings Estimates

Pulse Biosciences Environmental, Social, and Governance (ESG) Scores

Pulse Stock Institutional Investors

Note, although Pulse Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pulse Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 992.88 M.

Pulse Profitablity

Management Efficiency

Pulse Biosciences has return on total asset (ROA) of (0.3815) % which means that it has lost $0.3815 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7028) %, meaning that it created substantial loss on money invested by shareholders. Pulse Biosciences' management efficiency ratios could be used to measure how well Pulse Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of January 4, 2025, Return On Tangible Assets is expected to decline to -0.94. In addition to that, Return On Capital Employed is expected to decline to -1. At present, Pulse Biosciences' Debt To Assets are projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 0.11, whereas Net Tangible Assets are forecasted to decline to about 26.1 M.

Technical Drivers

As of the 4th of January, Pulse Biosciences holds the Coefficient Of Variation of 1328.03, risk adjusted performance of 0.0695, and Semi Deviation of 4.21. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulse Biosciences, as well as the relationship between them. Please check Pulse Biosciences treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Pulse Biosciences is priced some-what accurately, providing market reflects its current price of 19.63 per share. Given that Pulse Biosciences has jensen alpha of 0.3658, we recommend you to check out Pulse Biosciences's recent market performance to make sure the company can sustain itself at a future point.

Pulse Biosciences Price Movement Analysis

Pulse Biosciences Insider Trading Activities

Pulse Biosciences Outstanding Bonds

Pulse Biosciences Predictive Daily Indicators

Pulse Biosciences Corporate Filings

Pulse Biosciences Forecast Models

Pulse Biosciences' time-series forecasting models are one of many Pulse Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pulse Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pulse Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pulse shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pulse Biosciences. By using and applying Pulse Stock analysis, traders can create a robust methodology for identifying Pulse entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pulse analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pulse analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pulse Biosciences stock analysis indicators help investors evaluate how Pulse Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pulse Biosciences shares will generate the highest return on investment. By understating and applying Pulse Biosciences stock analysis, traders can identify Pulse Biosciences position entry and exit signals to maximize returns.

When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.